Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CBIO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
CBIO
Crescent Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
CBIO
Crescent Biopharma, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
CBIO
with
LLY
No shared trading history for CBIO and LLY.
Shared co-movers: not yet measured (CBIO).
CBIO, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
CBIO
Crescent Biopharma, Inc.
Change
13.80
▲
+6.68%
· post 13.28
Mkt cap
$480.6M
Revenue
$1M
Q1 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
CBIO
Crescent Biopharma, Inc.
vs
LLY
ELI Lilly & Co
13.80
▲
+6.68%
post 13.28
Price
1,360.90
▼
−0.28%
post 1,358.90
$480.6M
Mkt cap
$1.2T
Q1 FY26
$1M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
CBIO
13.80
▲
+6.68%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26